ArticleInternational journal of clinical pharmacy2025
Developing a pharmacist preceptorship programme to support UK advanced level practice: a consensus study.
Article in International journal of clinical pharmacy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Developing pharmacist practice through a pilot family practice preceptorship programme: a prospective quantitative pre-post evaluation.International journal of clinical pharmacy · 2026Article
- Feasibility of a pilot preceptorship programme for pharmacists working towards the advanced career stage in Scotland: a mixed-methods study.International journal of clinical pharmacy · 2026Article
- Pharmacists' views on barriers and enablers to the implementation of advanced pharmacist prescribing in Scotland: a qualitative study using normalisation process theory.International journal of clinical pharmacy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGlobally, health professionals are advancing roles to meet growing healthcare demands. Pharmacists are increasingly required to deliver autonomous, holistic, highly complex advanced care. Preceptorship could be used more widely to support delivery of advanced pharmaceutical care.
aimThe aim of this study was to formulate statements describing features of preceptorship programmes, and to measure consensus in the Scottish pharmacy workforce on the applicability of these statements to an advanced pharmacist preceptorship programme.
methodPhase 1-formulation of statements relating to key features of healthcare preceptorship programmes through literature review and author expertise. Phase 2-modified nominal group technique (m-NGT) to add expert ideas to phase 1 statements and to reach consensus on statement wording. Phase 3-a two round modified Delphi (m-Delphi) survey to measure consensus in the Scottish pharmacy workforce on whether the features presented should be part of a Scottish advanced pharmacist preceptorship programme. Consensus agreement was set at 75% for m-NGT and m-Delphi.
resultsFifty-one statements were generated from literature. Seven statements were generated by authors. Three statements were generated by experts during m-NGT stage: 61 statements progressed to m-Delphi. After two rounds (n = 194 and 144 participants in round one and two respectively) of m-Delphi, consensus was reached on 48 of the 61 statements across categories including programme design, preceptor training requirements and programme assessment.
conclusionThis study provides a strong basis for research into the impact of preceptorship programmes for pharmacists working towards the advanced career stage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.